Serious hypersensitivity (allergic) reactions may occur.
GENERIC AVAILABLE: Yes
PREPARATIONS: Intravenous powder for solution: 500 mg/vial and 1 gram/vial.
STORAGE: Meropenem should be stored at room temperature, 20 C to 25 C (68 F to 77 F).
- For the treatment of complicated skin infections in adults, 500 mg to 2 grams should be administered intravenously every 8 hours.
- For abdominal infections, 1 to 2 grams should be administered intravenously every 8 hours.
DRUG INTERACTIONS: Meropenem should not be combined with valproic acid (Depakene) or divalproex (Depakote) because meropenem may reduce absorption of valproic acid and divalproex from the intestine and increase elimination of the drugs through the kidneys thereby reducing the levels of these drugs in the body and reducing their effectiveness.
Probenecid (Benemid) may increase levels of meropenem by reducing its elimination through the kidneys. Increased levels of meropenem in the body could increase side effects like nausea, vomiting, and headache.
PREGNANCY: Safe and effective use of meropenem is not established in pregnant females. Therefore, it should be used only if clearly needed.
NURSING MOTHERS: It is not known whether meropenem enters breast milk.
REFERENCE: FDA Prescribing Information.
Quick GuideInfectious Mononucleosis Pictures Slideshow
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Need help identifying pills and medications?
Use the pill identifier tool on RxList.